scispace - formally typeset
P

Philippe Autier

Researcher at University of Strathclyde

Publications -  275
Citations -  20722

Philippe Autier is an academic researcher from University of Strathclyde. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 63, co-authored 272 publications receiving 19151 citations. Previous affiliations of Philippe Autier include Erasmus University Rotterdam & Université libre de Bruxelles.

Papers
More filters
Journal ArticleDOI

Estimates of the cancer incidence and mortality in Europe in 2006

TL;DR: The total number of new cases of cancer in Europe appears to have increased by 300,000 since 2004 and the ageing of the European population will cause these numbers to continue to increase even if age-specific rates remain constant.
Journal ArticleDOI

Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials

TL;DR: In this paper, the authors examined the risk of dying from any cause in subjects who participated in randomized trials testing the impact of vitamin D supplementation (ergocalciferol [vitamin D 2 ] or cholecalciferols [v vitamin D 3 ]) on any health condition.
Journal ArticleDOI

Vitamin D status and ill health: a systematic review

TL;DR: The discrepancy between observational and intervention studies suggests that low 25(OH)D is a marker of ill health, and restoration of vitamin D deficits due to ageing and lifestyle changes induced by ill health could explain why low-dose supplementation leads to slight gains in survival.
Journal ArticleDOI

Delivering affordable cancer care in high-income countries

TL;DR: Urgent solutions range from re-engineering of the macroeconomic basis of cancer costs (eg, value-based approaches to bend the cost curve and allow cost-saving technologies), greater education of policy makers, and an informed and transparent regulatory system.
Journal ArticleDOI

Cutaneous melanoma attributable to sunbed use : systematic review and meta-analysis

TL;DR: Sunbed use is associated with a significant increase in risk of melanoma, this risk increases with number of sunbed sessions and with initial usage at a young age (<35 years), which could be avoided by strict regulations.